Enteroviral meningoencephalitis as complication of Rituximab therapy in a patient treated for diffuse large B-cell lymphoma.
Servais
Sophie
S
Caers
Jo
J
Warling
Odile
O
Frusch
Nicolas
N
Baron
Frédéric
F
De Prijck
Bernard
B
Beguin
Yves
Y
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000009:adverse effects*; D004769:Enterovirus Infections / Q000139:chemically induced*; D005260:Female; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy*; D008279:Magnetic Resonance Imaging; D008590:Meningoencephalitis / Q000139:chemically induced*; D008875:Middle Aged; D009894:Opportunistic Infections / Q000139:chemically induced; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab